Concepedia

Amy C. Hart

AC

Statistics

Publications

12

Citations

440

H-Index

12

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Wisconsin–Madison

University of Colorado Boulder

Glasgow Royal Infirmary

Amy C. Hart is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicinal chemistry, and structural biology.

ORCID

Publications per year

1998–2022

12

Publications

12

Total Synthesis of (+)-Cylindramide A

Amy C. Hart, Andrew J. Phillips · Journal of the American Chemical Society · 2006 · 101 citations

, , +7

Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial

James Hill, S Lee, Dion Morton et al. · British journal of surgery · 2022 · 79 citations · Full text

, , +17

Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms

Honghe Wan, Gretchen M. Schroeder, Amy C. Hart et al. · ACS Medicinal Chemistry Letters · 2015 · 39 citations · Full text

, , +15

Pathogenic Activation of Mesenchymal Stem Cells Is Induced by the Disease Microenvironment in Systemic Sclerosis

Zeinab Taki, Elena V. Gostjeva, William G. Thilly et al. · Arthritis & Rheumatology · 2020 · 37 citations

, , +14

Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage

Amy C. Hart, Lynn M. Abell, Junqing Guo et al. · ACS Medicinal Chemistry Letters · 2019 · 35 citations · Full text

, , +14

1–5 of 12